United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
MILWAUKEE, Dec. 03, 2015 (GLOBE NEWSWIRE) -- We are investigating the Board of Directors of ARPI for possible breaches of fiduciary duty and other violations of state law in connection with the sale of ARPI to AMH.
Click here to learn how to join the action: http://www.ademilaw.com/case/arpi or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
ARPI long-term financial outlook is improving and yet ARPI shareholders will receive only 1.135 common shares or limited partnership units of AMH. AMH is well aware of ARPI improving financial metrics and is purchasing ARPI at a substantial discount. The merger agreement unreasonably limits prospective bids for ARPI by (i) prohibiting solicitation of any further bids, and (ii) imposing a termination penalty should ARPI receive and accept a superior bid. ARPI insiders, their affiliates and other majority shareholders own significant voting stock, and will receive millions of dollars as part of change of control arrangements, and therefore can unduly influence a sale of ARPI not in the best interests of non-insiders. Our investigation centers on the conduct of ARPI Board of Directors, who have unanimously approved the transaction, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for ARPI given its current financial condition and prospects.
If you own common shares or limited partnership units in ARPI and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or http://www.ademilaw.com/case/arpi.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Ademi & O’Reilly, LLP Guri Ademi 3620 East Layton Ave. Cudahy, WI 53110 Toll Free: (866) 264-3995 Fax: (414) 482-8001 www.ademilaw.com
